LynxDx is a cancer diagnostics company with the mission to improve patient care by bringing novel diagnostic assays to the market. We are leveraging cutting edge genomic technologies and have performed robust validation studies to ensure that we are providing patients and physicians with trustworthy and clinically impactful tools for patient care.